Ignite Creation Date:
2024-05-06 @ 3:20 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04602078
Status:
COMPLETED
Last Update Posted:
2024-03-21
First Post:
2020-10-06
Brief Title:
Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma
Sponsor:
Spanish Oncology Genito-Urinary Group
Organization:
Spanish Oncology Genito-Urinary Group
Organization Data
Organization:
Spanish Oncology Genito-Urinary Group
Class:
OTHER
Study ID:
SOGUG-2020-IECVEJ-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spanish Oncology Genito-Urinary Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Roche Pharma AG | INDUSTRY |